Viewing Study NCT07168161


Ignite Creation Date: 2025-12-24 @ 12:49 PM
Ignite Modification Date: 2026-04-03 @ 6:06 PM
Study NCT ID: NCT07168161
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: STS-BDB001-10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators